Castle Biosciences Inc
Nasdaq · Healthcare · Services-Medical Laboratories · Friendswood, TX
CSTL chart
What traders are saying about $CSTL
Latest postsCastle Biosciences Inc news
- Castle Biosciences (NASDAQ:CSTL) Stock Bumped Down to "Hold" by Wall Street Zen
MarketBeat ·
- Castle Biosciences (CSTL) Shares New TissueCypher Data, Is The Stock 42% Below Fair Value?
Simply Wall Street ·
- How Investors Are Reacting To Castle Biosciences (CSTL) TissueCypher Study Data
Simply Wall Street ·
- Castle Biosciences CEO Derek Maetzold sells $462,567 in stock
Investing.com ·
- Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 8,580 Shares of Company Stock
MarketBeat ·
- Form 4 Castle Biosciences Inc: Derek J. Maetzold (Director, Pres. & Chief Exec. Officer) For: 19 October
Investing.com South Africa ·
- Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026
Yahoo Finance ·
- ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus
Yahoo Finance ·
- New Melanoma Study Backing DecisionDx-Melanoma Could Be A Game Changer For Castle Biosciences (CSTL)
Yahoo Finance ·
- Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management
Yahoo Finance ·
- New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
Yahoo Finance ·
- New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™
Yahoo Finance ·
Castle Biosciences Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $344.2M | $332.1M | $219.8M | $137.0M |
| Net income | -$24.2M | $18.2M | -$57.5M | -$67.1M |
| Diluted EPS | $-0.83 | $0.62 | $-2.14 | $-2.58 |
| Total assets (year end) | $578.6M | $531.2M | $453.3M | $447.3M |
| Cash and equivalents (year end) | $116.7M | $119.7M | $98.8M | $122.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Castle Biosciences Inc
- Ticker
- CSTL (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- Friendswood, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1447362
Frequently asked questions
What exchange is Castle Biosciences Inc listed on?
Castle Biosciences Inc trades on the Nasdaq under the ticker symbol CSTL.
What industry is Castle Biosciences Inc in?
Castle Biosciences Inc is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is Castle Biosciences Inc headquartered?
Castle Biosciences Inc's business address on file with the SEC is in Friendswood, TX.
When does Castle Biosciences Inc's fiscal year end?
Castle Biosciences Inc's fiscal year ends on December 31.
How much revenue did Castle Biosciences Inc report?
Castle Biosciences Inc reported $344.2M in revenue for calendar year 2025, according to its SEC filings.